Clinical Trial Update: to Evaluate the Safety/Tolerability and Pharmacokinetics, and Pharmacodynamics of DWP14012 Injection [Phase 1]

View source ↗

Summary

A Phase 1 trial to evaluate safety, tolerability, pharmacokinetics, and pharmacodynamics of DWP14012 injection in erosive gastroesophageal reflux disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophagitis Erosive
• Gastroesophageal Reflux Disease

Drugs mentioned

• DWP14012

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Erosive Gastroesophageal Reflux Disease | Phase 1 | Status: NOT_YET_RECRUITING